MariMed Client FSCC Opens Delaware’s 2nd Medical Cannabis Facility
Jun 01, 2017 12:45 pm UTC| Business
LEWES, Del., June 01, 2017 -- MariMed Inc. (OTCQB:MRMD) client First State Compassion Center (FSCC), opened Delaware’s second licensed medical cannabis facility after successfully operating the first one in Wilmington,...
MariMed Client FSCC Opens Delaware’s 2nd Medical Cannabis Facility
Jun 01, 2017 12:45 pm UTC| Business
LEWES, Del., June 01, 2017 -- MariMed Inc. (OTCQB:MRMD) client First State Compassion Center (FSCC), opened Delaware’s second licensed medical cannabis facility after successfully operating the first one in Wilmington,...
MariMed Client FSCC Opens Delaware’s 2nd Medical Cannabis Facility
Jun 01, 2017 12:45 pm UTC| Business
LEWES, Del., June 01, 2017 -- MariMed Inc. (OTCQB:MRMD) client First State Compassion Center (FSCC), opened Delaware’s second licensed medical cannabis facility after successfully operating the first one in Wilmington,...
MariMed Client FSCC Opens Delaware’s 2nd Medical Cannabis Facility
Jun 01, 2017 12:45 pm UTC| Business
LEWES, Del., June 01, 2017 -- MariMed Inc. (OTCQB:MRMD) client First State Compassion Center (FSCC), opened Delaware’s second licensed medical cannabis facility after successfully operating the first one in Wilmington,...
MariMed Client FSCC Opens Delaware’s 2nd Medical Cannabis Facility
Jun 01, 2017 12:45 pm UTC| Business
LEWES, Del., June 01, 2017 -- MariMed Inc. (OTCQB:MRMD) client First State Compassion Center (FSCC), opened Delaware’s second licensed medical cannabis facility after successfully operating the first one in Wilmington,...
MariMed Client FSCC Opens Delaware’s 2nd Medical Cannabis Facility
Jun 01, 2017 12:45 pm UTC| Business
LEWES, Del., June 01, 2017 -- MariMed Inc. (OTCQB:MRMD) client First State Compassion Center (FSCC), opened Delaware’s second licensed medical cannabis facility after successfully operating the first one in Wilmington,...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...